TOMI Environmental Solutions, Inc. specializing in proprietary hydrogen peroxide-based SteraMist technology for disinfection and decontamination, appears undervalued despite a post-COVID-19 demand slump. With shares down over 94% from their peak, the market overlooks TOMI's resurgence potential, underscored by expected 25% annual EPS growth from $0.06 in 2024 to $0.74 by 2032, and a 109% sales increase next year. The company's recent $600,000 contract with a California-based life sciences company for a SteraMist iHP Custom Engineered System signifies its growing appeal in sectors prioritizing advanced decontamination solutions, showcasing its promising future and investment potential amidst evolving market dynamics and expanding industry applications.
Going to try a small position here at the range LVN, if we trade lower im going to double down.
Going to try a small position here at the range LVN, if we trade lower im going to double down.
交易進行
Averaged down here with a large buy 64 cents.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。